TRX-818 sodium|Foslinanib sodium

Cas No.:	1256037-62-3
Chemical Name:	sodium (2-(3-fluorophenyl)-6-methoxy-4-oxo-1,4-dihydroquinolin-5-yl)phosphonate
Synonyms:	Foslinanib sodium
SMILES:	[Na+].[Na+].N1C2=C(C(P(=O)([O-])[O-])=C(OC)C=C2)C(=O)C=C1C1=CC=CC(F)=C1
Formula:	C₁₆H₁₁FNNa₂O₅P
M.Wt:	393.218
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Description:

TRX-818 sodium (Foslinanib sodium ) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities, induces cancer cell apoptosis and inhibits cancer cell proliferation; also prevents tumor cell VM by blocking the formation of vasculogenic-like tubular structures through an as of yet undetermined mechanism of action.

Cat. No.	Product name	Field of application
DC11087	TRX-818 sodium	TRX-818 sodium (Foslinanib sodium ) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities, induces cancer cell apoptosis and inhibits cancer cell proliferation.
DC11086	Foslinanib	Foslinanib (TRX-818) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities, induces cancer cell apoptosis and inhibits cancer cell proliferation.